How Two Common Medications Became One $455 Million Specialty Pill — ProPublica
Celebrex Is Found to Be No Riskier for Hearts Than Other Pain Drugs - The New York Times
Opinion | Placebo Effect is Powerful - The New York Times
How to Manage Mismatched Sex Drive in a Relationship - The New York Times
What is Berberine? What to Know About the Supplement and Weight Loss - The New York Times
Guest Essays - The New York Times
The Mystery of My Burning Esophagus - The New York Times
A Pill to Treat Covid-19? The U.S. Is Betting on It. - The New York Times
New questions about old Canadian study foreshadowing opioid crisis | CBC News
Opioids in America
Herpes Can Be Devastating but Treatment and Testing Remain Scant - The New York Times
How to Get Heart Patients to Take Their Pills? Give Them Just One. - The New York Times
Antiviral Pills Like Paxlovid Help Treat Covid. Here's How to Get Them. - The New York Times
C.D.C. Painkiller Guidelines Aim to Reduce Addiction Risk - The New York Times
How OxyContin's Pain Relief Built 'A World Of Hurt' : NPR
The Covid-19 Pandemic - The New York Times
Practice Fusion took kickbacks to push opioids to doctors, DOJ finds
Picking the Right Over-the-Counter Pain Reliever - The New York Times
Walgreens Pain Reliever PM Extra Strength Capsules | Walgreens
The Prescription Drugs That Rich People Buy - The New York Times
Is Ibuprofen Really Risky for Coronavirus Patients? - The New York Times
Opioids Aren't the Only Pain Drugs to Fear - The New York Times
Common Medications Can Prolong Back Pain, Study Says - The New York Times
Sharp Rise Reported in Older Americans' Use of Multiple Psychotropic Drugs - The New York Times
FDA Approves New Drug to Treat Hot Flashes - The New York Times
Opinion | The Insanity of Taxpayer-Funded Addiction - The New York Times
